Home

Aptus Pharma PE Ratio

From Blinkx's GPT

No data available

Key Highlights

  • The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years.
  • The Latest Trading Price of Aptus Pharma Ltd is ₹ 84.84 as of 30 Sep 15:17 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 37.9 in 5 years. This represents a CAGR of 12.43%.
  • The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.0. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Pharmaceuticals industry is 32.5. The PE Ratio of Retail industry is 123.8. The PE Ratio of Textiles industry is 54.7 in 2025.

Historical P/E Ratio of Aptus Pharma Ltd

No data available

Company Fundamentals for Aptus Pharma Ltd

Image

Aptus Pharma Ltd

NSE: APPL

Share Price

₹ 84.84

14.84 (21.20%)

stock direction

Last updated on: Sep 30, 2025

Market Price of Aptus Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aptus Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

BlinkX Score for Aptus Pharma Ltd

Asset Value vs Market Value of Aptus Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Aptus Pharma Ltd Explained

0

Market cap

3

Earnings

0.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aptus Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aptus Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aptus Pharma Ltd

No data available

* All values are in %

About Aptus Pharma Ltd

  • Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
  • Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
  • While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
  • It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

Aptus Pharma Ltd News Hub

Shares of Aptus Pharma list in MT Group

The equity shares of Aptus Pharma (Scrip Code: 544529) are listed effective 30 September 2025 and ad

Read more

30 Sept 25

BSE SME Aptus Pharma cures listing-day jitters with premium opening

The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The

Read more

30 Sept 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions